Urology

Letter from the editor
pp. 307-309(3)

Hand-assisted laparoscopy: pro
pp. 310-312(3)
Author: Wolf J.S.

Hand-assisted laparoscopy: con
pp. 313-317(5)
Author: Gill I.S.

Nutrition and prostate cancer: evidence or suspicion?
pp. 318-334(17)
Authors: Schulman C.C.; Ekane S.; Zlotta A.R.

DNA-based detection of prostate cancer in urine after prostatic massage
pp. 335-338(4)
Authors: Goessl C.; Muller M.; Heicappell R.; Krause H.; Straub B.; Schrader M.; Miller K.

Pilot trial of bacterial interference for preventing urinary tract infection
pp. 339-344(6)
Authors: Darouiche R.O.; Donovan W.H.; Del Terzo M.; Thornby J.I.; Rudy D.C.; Hull R.A.

Editorial comment
pp. 344-344(1)
Author: Lowe F.C.

Prospective randomized study of various techniques of percutaneous nephrolithotomy
pp. 345-350(6)
Authors: Feng M.I.; Tamaddon K.; Mikhail A.; Kaptein J.S.; Bellman G.C.

Comparison of outcomes of ureteroscopy for ureteral calculi located above and below the pelvic brim
pp. 351-355(5)
Authors: Hollenbeck B.K.; Schuster T.G.; Faerber G.J.; Wolf J.S.

Editorial comment
pp. 355-356(2)
Author: Bagley D.H.

Laparoscopic renal cryoablation: impact on renal function and blood pressure
pp. 357-361(5)
Authors: Carvalhal E.F.; Gill I.S.; Meraney A.M.; Desai M.M.; Schweizer D.K.; Sung G.T.

Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report
pp. 362-366(5)
Authors: Lodde M.; Mian C.; Wiener H.; Haitel A.; Pycha A.; Marberger M.

Diagnostic efficacy of the Immunocyt test to detect superficial bladder cancer recurrence
pp. 367-371(5)
Authors: Vriesema J.L.J.; Atsma F.; Kiemeney L.A.L.M.; Peelen W.P.; Witjes J.A.; Schalken J.A.

Autofluorescence imaging to optimize 5-ALA-induced fluorescence endoscopy of bladder carcinoma
pp. 372-375(4)
Authors: Frimberger D.; Zaak D.; Stepp H.; Knuchel R.; Baumgartner R.; Schneede P.; Schmeller N.; Hofstetter A.

Risk of continued intravesical therapy and delayed cystectomy in BCG-refractory superficial bladder cancer: an investigational approach
pp. 376-379(4)
Authors: Luciani L.G.; Neulander E.; Murphy W.M.; Wajsman Z.

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder
pp. 380-385(6)
Authors: Zietman A.L.; Grocela J.; Zehr E.; Kaufman D.S.; Young R.H.; Althausen A.F.; Heney N.M.; Shipley W.U.

Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status
pp. 386-392(7)
Authors: Moreno J.G.; O'Hara S.M.; Gross S.; Doyle G.; Fritsche H.; Gomella L.G.; Terstappen L.W.M.M.

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer
pp. 393-399(7)
Authors: Kattan M.W.; Potters L.; Blasko J.C.; Beyer D.C.; Fearn P.; Cavanagh W.; Leibel S.; Scardino P.T.

Using the receiver operating characteristic curve to select pretreatment and pathologic predictors for early and late postprostatectomy PSA failure
pp. 400-405(6)
Authors: Cheung R.; Altschuler M.D.; D'Amico A.V.; Malkowicz S.B.; Wein A.J.; Whittington R.

Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening
pp. 406-410(5)
Authors: D'Amico A.V.; Whittington R.; Malkowicz S.B.; Renshaw A.A.; Tomaszewski J.E.; Bentley C.; Schultz D.; Rocha S.; Wein A.; Richie J.P.

Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging
pp. 411-416(6)
Authors: Fang J.; Metter E.J.; Landis P.; Chan D.W.; Morrell C.H.; Carter H.B.

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria¹
pp. 417-424(8)
Authors: Bartsch G.; Horninger W.; Klocker H.; Reissigl A.; Oberaigner W.; Schonitzer D.; Severi G.; Robertson C.; Boyle P.; the Tyrol Prostate Cancer Screening Group

Editorial comment
pp. 424-424(1)
Author: Carter H.B.

Early removal of urinary catheter after radical retropubic prostatectomy is both feasible and desirable
pp. 425-429(5)
Authors: Lepor H.; Nieder A.M.; Fraiman M.C.

Patient-reported experience with the Viadur 12-month leuprolide implant for prostate cancer
pp. 430-434(5)
Authors: Fowler J.E.; the Viadur Study Group

Cavernous and systemic testosterone plasma levels during different penile conditions in healthy males and patients with erectile dysfunction
pp. 435-440(6)
Authors: Becker A.J.; Uckert S.; Stief C.G.; Scheller F.; Knapp W.H.; Hartmann U.; Jonas U.

Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction
pp. 441-445(5)
Authors: Kim S.W.; Paick J.-S.; Park D.W.; Chae I.-H.; Oh B.-H.

Creatine kinase as an indicator of sperm quality and maturity in men with oligospermia
pp. 446-451(6)
Authors: Hallak J.; Sharma R.K.; Pasqualotto F.F.; Ranganathan P.; Thomas A.J.; Agarwal A.

Magnetic resonance imaging in the evaluation of congenital anomalies of the external genitalia
pp. 452-456(5)
Authors: Lapointe S.P.; Wei D.C.; Hricak H.; Varghese S.L.; Kogan B.A.; Baskin L.S.

Percutaneous endoscopic management of urothelial tumors of the renal pelvis
pp. 457-459(3)
Authors: Potter S.R.; Chow G.K.; Jarrett T.W.

Upper tract air
pp. 460-461(2)
Authors: Trainer A.F.; L'Esperance J.O.; Bamberger M.H.

Arterial priapism and cycling: a new worrisome reality?
pp. 462-462(1)
Authors: De Rose A.F.; Giglio M.; De Caro G.; Corbu C.; Traverso P.; Carmignani G.

Metanephric stromal tumor: a rare benign pediatric renal mass
pp. 462-462(1)
Authors: Palese M.A.; Ferrer F.; Perlman E.; Gearhart J.P.

Primary actinomycosis mimicking urachal carcinoma
pp. 462-462(1)
Authors: Yeung Y.; Cheung M.C.; Chan G.S.W.; Cheung A.N.Y.; Tam P.C.

Priapism from quetiapine overdose: first report and proposal of mechanism
pp. 462-462(1)
Authors: Pais V.M.; Ayvazian P.J.

Transverse testicular ectopia with supernumerary vas deferens and cyst of the ejaculatory duct
pp. 462-462(1)
Authors: Yiou R.; Lebret T.; Lugagne P.M.; Molinie V.; Herve J.-M.; Botto H.

Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival
pp. 462-462(1)
Authors: Kawakami S.; Kageyama Y.; Yonese J.; Fukui I.; Kitahara S.; Arai G.; Hyouchi N.; Suzuki M.; Masuda H.; Hayashi T.; Okuno T.; Kihara K.

Myocyte apoptosis in the pathogenesis of ureteral damage in rats with obstructive uropathy
pp. 463-470(8)
Authors: Chuang Y.-H.; Chuang W.-L.; Huang C.-H.

Increased F as ligand expression in the tumor tissue and serum of patients with testicular germ cell tumors with seminomatous elements
pp. 471-476(6)
Authors: Hara S.; Miyake H.; Nakamura I.; Arakawa S.; Kamidono S.; Hara I.

Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance
pp. 477-481(5)
Authors: Haitel A.; Wiener H.G.; Neudert B.; Marberger M.; Susani M.

Autologous, cadaveric, and synthetic materials used in sling surgery: comparative biomechanical analysis
pp. 482-486(5)
Authors: Choe J.M.; Kothandapani R.; James L.; Bowling D.

Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study
pp. 487-492(6)
Authors: Sahin M.; BaSar M.M.; Bozdogan O.; Atan A.

Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion
pp. 493-497(5)
Authors: Miyake O.; Kakimoto K.; Tsujihata M.; Yoshimura K.; Takahara S.; Okuyama A.

Penile prosthesis placement in the organ transplant patient
pp. 498-498(1)
Author: Williams C.B.

Penile Prosthesis Placement in the Organ Transplant Patient: Reply by the authors
pp. 498-498(1)
Authors: Cuellar D.C.; Sklar G.N.

Diagnostic accuracy of dna image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer
pp. 499-499(1)
Authors: Kouriefs C.; Gordon G.J.

Erratum
pp. 500-500(1)